Andrea Newkirk

Stock Analyst at Goldman Sachs

(2.80)

# 1,700

Out of 5,116 analysts

4

Total ratings

66.67%

Success rate

57.68%

Average return

Main Sectors:

Top Industries:

Health Information Services Biotechnology Drug Manufacturers - Specialty & Generic

Stocks Rated by Andrea Newkirk

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	SDGR Schrödinger	Initiates: Neutral	$19	$18.31	+3.77%	1	Sep 30, 2025
	RVMD Revolution Medicines	Maintains: Buy	$65 → $73	$80.75	-9.60%	2	Sep 12, 2025
	ALKS Alkermes	Initiates: Buy	$43	$28.49	+50.93%	1	Jul 15, 2025

Schrödinger

Sep 30, 2025

Initiates: Neutral

Price Target: $19

Current: $18.31

Upside: +3.77%

Revolution Medicines

Sep 12, 2025

Maintains: Buy

Price Target: $65 → $73

Current: $80.75

Upside: -9.60%

Alkermes

Jul 15, 2025

Initiates: Buy

Price Target: $43

Current: $28.49

Upside: +50.93%